Age-related Macular Degeneration Beyond the Age-related Eye Disease Study II

  • Author Footnotes
    1 These authors contributed equally to this work, at different developmental phases.
    Stuart Richer
    Correspondence
    Corresponding author.
    Footnotes
    1 These authors contributed equally to this work, at different developmental phases.
    Affiliations
    Optometry/Ophthalmology, Captain James A Lovell Federal Heath Care Center, 3001 Green Bay Road, North Chicago, IL 60064, USA

    Retina, Illinois Eye & Ear Infirmary, LIERI Building, 1905 West Taylor Street, Chicago, IL 60612, USA

    Department of Family and Preventive Medicine, Rosalind Franklin University of Medicine & Science, 3333 Green Bay Road, North Chicago, IL 60064, USA

    Ophthalmology, Scripps Memorial Hospital, Scripps Mericos Eye Institute, Scripps Clinical Research Service, 9850 Genesee Avenue, Suite 310, La Jolla, CA 92037, USA
    Search for articles by this author
  • Lawrence Ulanski II
    Affiliations
    Optometry/Ophthalmology, Captain James A Lovell Federal Heath Care Center, 3001 Green Bay Road, North Chicago, IL 60064, USA

    Retina, Illinois Eye & Ear Infirmary, LIERI Building, 1905 West Taylor Street, Chicago, IL 60612, USA
    Search for articles by this author
  • Natalia A. Popenko
    Affiliations
    Optometry/Ophthalmology, Captain James A Lovell Federal Heath Care Center, 3001 Green Bay Road, North Chicago, IL 60064, USA

    Department of Family and Preventive Medicine, Rosalind Franklin University of Medicine & Science, 3333 Green Bay Road, North Chicago, IL 60064, USA
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to this work, at different developmental phases.
    Steven G. Pratt
    Footnotes
    1 These authors contributed equally to this work, at different developmental phases.
    Affiliations
    Ophthalmology, Scripps Memorial Hospital, Scripps Mericos Eye Institute, Scripps Clinical Research Service, 9850 Genesee Avenue, Suite 310, La Jolla, CA 92037, USA
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to this work, at different developmental phases.
    Dorothy Hitchmoth
    Footnotes
    1 These authors contributed equally to this work, at different developmental phases.
    Affiliations
    Optometry, White River Junction VA Medical Center, 215 North Main Street, White River Junction, VT 05009, USA
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to this work, at different developmental phases.
    Paul Chous
    Footnotes
    1 These authors contributed equally to this work, at different developmental phases.
    Affiliations
    Diabetic Retinopathy, Chous EyeCare Associates, 6720 Regents Boulevard, Tacoma, WA 98466, USA
    Search for articles by this author
  • Shana Patel
    Affiliations
    Department of Family and Preventive Medicine, Rosalind Franklin University of Medicine & Science, 3333 Green Bay Road, North Chicago, IL 60064, USA
    Search for articles by this author
  • Shivani Sockanathan
    Affiliations
    Department of Family and Preventive Medicine, Rosalind Franklin University of Medicine & Science, 3333 Green Bay Road, North Chicago, IL 60064, USA
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to this work, at different developmental phases.
    Bill Sardi
    Footnotes
    1 These authors contributed equally to this work, at different developmental phases.
    Affiliations
    Health and Nutrition, Resveratrol Partners, LLC, 5175 S. Durango Drive, Suite A, Las Vegas, NV 89113, USA
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to this work, at different developmental phases.
      Age-related macular degeneration (AMD) is age dependent with a gradual, insidious onset until the eighth decade of life when there is an exponential increase in the number of patients with this condition.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Ophthalmology and Optometry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Fischer T.
        Non-pharmacologic therapy of age related macular degeneration, based on the etiopathogenesis of the disease.
        Orv Hetil. 2015; 156: 1128-1132
        • Belsky D.W.
        • Caspi A.
        • Houts R.
        • et al.
        Quantification of biological aging in young adults.
        Proc Natl Acad Sci U S A. 2015; 112: E4104-E4110
        • Korb C.A.
        • Kottler U.B.
        • Wolfram C.
        • et al.
        Prevalence of age-related macular degeneration in a large European cohort: Results from the population-based Gutenberg Health Study.
        Graefes Arch Clin Exp Ophthalmol. 2014; 252: 1403-1411
        • Packer L.
        • Valacchi G.
        Antioxidants and the response of skin to oxidative stress: vitamin E as a key indicator.
        Skin Pharmacol Appl Skin Physiol. 2002; 15: 282-290
        • Hinz M.
        • Stein A.
        • Uncin T.
        Relative nutritional deficiencies associated with centrally acting monoamines.
        Int J Gen Med. 2012; 5: 413-430
        • Wallach J.
        • Lan M.
        • Schrauzer G.
        Epigenetics: the death of the genetic theory of disease transmission.
        1st edition. Select Books, New York2014
        • Ely J.J.
        Inadequate levels of essential nutrients in developed nations as a risk factor for disease: a review.
        Rev Environ Health. 2003; 18: 111-129
        • Meerson F.Z.
        • Malyshev I.I.u.
        • Belkina L.M.
        • et al.
        Enhanced resistance of the heart to arrhythmogenic factors as affected by adaptation of the body to stress exposures.
        Kardiologiia. 1988; 28: 70-74
        • Cohen S.M.
        • Olin K.L.
        • Feuer W.J.
        Low glutathione reductase and peroxidase activity in age related macular degeneration.
        Br J Ophthalmol. 1994; 78: 791-794
        • Millen A.E.
        • Meyers K.J.
        • Liu Z.
        • et al.
        Association between vitamin D status and age-related macular degeneration by genetic risk.
        JAMA Ophthalmol. 2015; 133: 1171-1179
        • Tan B.
        • Watson R.R.
        • Preedy V.R.
        Tocotrienols: vitamin E beyond tocotrienols.
        2nd edition. CRC Press, Taylor & Frances, Boca Raton (FL)2013: 377
        • Sulaiman R.S.
        • Basavarajappa H.D.
        • Corson T.W.
        Natural product inhibitors of ocular angiogenesis.
        Exp Eye Res. 2014; 129: 161-171
        • Kolte D.
        • Vijayaraghavan K.
        • Khera S.
        • et al.
        Role of magnesium in cardiovascular diseases.
        Cardiol Rev. 2014; 22: 182-192
        • Souied E.H.
        • Aslam T.
        • Garcia-Layana A.
        • et al.
        Omega-3 fatty acids and age-related macular degeneration.
        Ophthalmic Res. 2015; 55: 62-69
        • Mance T.C.
        • Kovacević D.
        • Alpeza-Dunato Z.
        • et al.
        The role of omega6 to omega3 ratio in development and progression of age-related macular degeneration.
        Coll Antropol. 2011; 35: 307-310
        • Chew E.Y.
        • Clemons T.E.
        • SanGiovanni J.P.
        • et al.
        AREDS2 Research Group. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
        JAMA Ophthalmol. 2014; 132: 142-149
        • Olk J.
        • Peralta E.
        • Gierhart D.L.
        • et al.
        Triple combination therapy and zeaxanthin for the treatment of neovascular age-related macular degeneration: an interventional comparative study and cost-effectiveness analysis.
        Internat J Ret Vit. 2015; 1 (ClinicalTrials.gov Identifier: NCT 01527435): 22
        • Yusof S.
        • Hawken S.
        • Ounpuu S.
        • et al.
        Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.
        Lancet. 2004; 364: 937-952
        • Levy T.E.
        Stop America’s #1 killer.
        Livon Books, Henderson (NV)2006
      1. Ely JTA. Orthomolecular.org. 2014. Available at: http://orthomolecular.org/hof/index.shtml. Accessed 20 June, 2016.

        • Bürzle M.
        • Hediger M.A.
        Functional and physiological role of vitamin C transporters.
        Curr Top Membr. 2012; 70: 357-375
        • Cohen S.
        Drug muggers.
        Rodale Press, New York2011: 371 (Available at:)
        • Huang P.
        • Wang F.
        • Sah B.K.
        • et al.
        Homocysteine and the risk of age-related macular degeneration: a systematic review and meta-analysis.
        Sci Rep. 2015; 5: 10585
        • Hahn P.
        • Qian Y.
        • Dentchev T.
        • et al.
        Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration.
        Proc Natl Acad Sci U S A. 2004; 101: 13850-13855
        • Brewer G.J.
        Risks of copper and iron toxicity during aging in humans.
        Chem Res Toxicol. 2010; 23: 319-326
      2. Sardi B. How does a cigar smoking man live to 110 years? 2014. Available at: http://www.resveratrolnews.com/how-does-cigar-smoking-man-live-110-years/980/. Accessed 20 June, 2016.

        • Farkas R.H.
        • Chowers I.
        • Hackam A.S.
        • et al.
        Increased expression of iron-regulating genes in monkey and human glaucoma.
        Invest Ophthalmol Vis Sci. 2004; 45: 1410-1417
        • Pizzi C.
        ‘Mild’ nonobstructive coronary artery disease is often anything but.
        J Cardiovasc Med (Hagerstown). 2011; 12: 697-699
        • Chong E.W.
        • Simpson J.A.
        • Robman L.D.
        • et al.
        Red meat and chicken consumption and its association with age-related macular degeneration.
        Am J Epidemiol. 2009; 169: 867-876
        • Stroh M.
        • Swerdlow R.H.
        • Zhu H.
        Common defects of mitochondria and iron in neurodegeneration and diabetes (MIND): a paradigm worth exploring.
        Biochem Pharmacol. 2014; 88: 573-583
        • Höhn A.
        • Jung T.
        • Grimm S.
        • et al.
        Lipofuscin-bound iron is a major intracellular source of oxidants: Role in senescent cells.
        Free Radic Biol Med. 2010; 48: 1100-1108
        • He M.
        • van Dam R.M.
        • Rimm E.
        • et al.
        Whole-grain, cereal fiber, bran, and germ intake and the risks of all-cause and cardiovascular disease-specific mortality among women with type 2 diabetes mellitus.
        Circulation. 2010; 121: 2162-2168
        • Holay M.P.
        • Choudhary A.A.
        • Suryawanshi S.D.
        Serum ferritin-a novel risk factor in acute myocardial infarction.
        Indian Heart J. 2012; 64: 173-177
        • Weinberg E.D.
        The hazards of iron loading.
        Metallomics. 2010; 2: 732-740
        • Van der Schaft T.L.
        • Mooy C.M.
        • de Bruijn W.C.
        • et al.
        Histologic features of the early stages of age-related macular degeneration. A statistical analysis.
        Ophthalmology. 1992; 99: 278-286
        • Reid I.R.
        Should we prescribe calcium supplements for osteoporosis prevention?.
        J Bone Metab. 2014; 21: 21-28
        • Tuohy K.M.
        • Fava F.
        • Viola R.
        ‘The way to a man's heart is through his gut microbiota'–dietary pro- and prebiotics for the management of cardiovascular risk.
        Proc Nutr Soc. 2014; 73: 172-185
        • Alibek K.
        • Grechanyĭ L.
        • Klimenko T.
        • et al.
        A fifth revolution in medicine: on the role of infections in pathogenesis of aging and chronic diseases.
        Lik Sprava. 2008; : 3-30
        • Sales N.M.
        • Pelegrini P.B.
        • Goersch M.C.
        Nutrigenomics: definitions and advances of this new science.
        J Nutr Metab. 2014; 2014: 202759
      3. Systems biology approaches to drug discovery single gene targeting is not enough. The New York Academy of Sciences. New York. Available at: http://www.nyas.org/Events/Detail.aspx?cid=073a364a-af58-49e0-896e-499e51427b66. Accessed 16 June, 2016.

        • Awh C.C.
        • Lane A.M.
        • Hawken S.
        • et al.
        CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration.
        Ophthalmology. 2013; 120: 2317-2323
        • Wang J.J.
        • Buitendijk G.H.
        • Rochtchina E.
        • et al.
        Genetic susceptibility, dietary antioxidants, and long-term incidence of age-related macular degeneration in two populations.
        Ophthalmology. 2014; 121: 667-675
        • He S.
        • Li X.
        • Chan N.
        • et al.
        Review: epigenetic mechanisms in ocular disease.
        Mol Vis. 2013; 19: 665-674
        • Colman R.J.
        • Beasley T.M.
        • Kemnitz J.W.
        • et al.
        Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys.
        Nature Communications, 2014 (Available at:)
        • Duffy P.H.
        • Seng J.E.
        • Lewis S.M.
        • et al.
        The effects of different levels of dietary restriction on aging and survival in the Sprague-Dawley rat: implications for chronic studies.
        Aging (Milano). 2001; 13: 263-272
        • Meerson F.Z.
        • Ustinova E.E.
        • Orlova E.H.
        Prevention and elimination of heart arrhythmias by adaptation to intermittent high altitude hypoxia.
        Clin Cardiol. 1987; 10: 783-789
        • Downey J.
        • Cohen M.V.
        Why do we still not have cardioprotective drugs?.
        Circ J. 2009; 73 ([review]): 1171-1177
        • Juhasz B.
        • Mukherjee S.
        • Das D.K.
        Hormetic response of resveratrol against cardioprotection.
        Exp Clin Cardiol. 2010; 15: 134-138
        • Adams M.K.
        • Chong E.W.
        • Williamson E.
        • et al.
        20/20–Alcohol and age-related macular degeneration: The Melbourne Collaborative Cohort Study.
        Am J Epidemiol. 2012; 176: 289-298
        • Renaud S.
        • de Lorgeril M.
        Wine, alcohol, platelets, and the French paradox for coronary heart disease.
        Lancet. 1992; 339: 1523-1526
        • Broadhead G.K.
        • Hong T.
        • Chang A.A.
        Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration.
        Acta Ophthalmol. 2014; 92: 713-723
        • Nagineni C.N.
        • Raju R.
        • Nagineni K.K.
        • et al.
        Resveratrol suppresses expression of VEGF by human retinal pigment epithelial cells: potential nutraceutical for age-related macular degeneration.
        Aging Dis. 2014; 5: 88-100
        • Katz M.L.
        • White H.A.
        • Gao C.L.
        • et al.
        Dietary restriction slows age pigment accumulation in the retinal pigment epithelium.
        Invest Ophthalmol Vis Sci. 1993; 34: 3297-3302
        • Mukhopadhyay P.
        • Mukherjee S.
        • Ahsan K.
        • et al.
        Restoration of altered microRNA expression in the ischemic heart with resveratrol.
        PLoS One. 2010; 5: e15705
        • Barger J.L.
        • Kayo T.
        • Pugh T.D.
        • et al.
        Short-term consumption of a resveratrol-containing nutraceutical mixture mimics gene expression of long-term caloric restriction in mouse heart.
        Exp Gerontol. 2008; 43: 859-866
        • Sangeetha M.K.
        • Valiabi D.E.
        • Sali V.K.
        • et al.
        Sub-acute toxicity profile of a modified resveratrol supplement.
        Food Chem Toxicol. 2013; 59: 492-500
        • Fujitaka A.
        • Otani H.
        • Jo F.
        • et al.
        Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment.
        Nutr Res. 2011; 31: 842-847
        • Wang S.
        • Moonasar N.
        • Xiao X.
        • et al.
        Effect of resveratrol-based nutritional supplement on choroidal thickness: a pilot study.
        Curr Eye Res. 2016; 10: 1-7
        • Tian Y.
        • Kijlsta A.
        • van der Veen R.L.
        • et al.
        The effect of lutein supplementation on blood plasma levels of complement factor D, C5a and C3d.
        PLoS One. 2013; 8: e73387
      4. Available at: http://www.longevinex.com/pdf/LongevinexAMDFDAPetition.pdf. Accessed 20 June, 2016.

        • Nakata Y.
        • Maeda N.
        Vulnerable atherosclerotic plaque morphology in apolipoprotein E-deficient mice unable to make ascorbic Acid.
        Circulation. 2002; 105: 1485-1490
        • Goldstein J.A.
        • Demetriou D.
        • Grines C.L.
        • et al.
        Multiple complex coronary plaques in patients with acute myocardial infarction.
        N Engl J Med. 2000; 343: 915-922
        • Wahlqvist M.L.
        • Tanaka K.
        • Tzeng B.H.
        Clinical decision-making for vitamin K-1 and K-2 deficiency and coronary artery calcification with warfarin therapy: are diet, factor Xa inhibitors or both the answer?.
        Asia Pac J Clin Nutr. 2013; 22: 492-496
        • Steinberg B.A.
        • Piccini J.P.
        State of the Art Review: Anticoagulation in atrial fibrillation.
        BMJ. 2014; 348 (g2116)
        • Silverman M.G.
        • Blaha M.J.
        • Krumholz H.M.
        • et al.
        Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis.
        Eur Heart J. 2014; 35: 2232-2241
        • Davidson B.L.
        • Verheijen S.
        • Lensing
        • et al.
        Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin.
        JAMA Intern Med. 2014; 174: 947-953